SCHEMBL64615

SCHEMBL64615

CCN1CCCC(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2928953 0.98 CYP2D6 (0.38)
Bromide SCHEMBL3733597 0.98 CYP2D6 (0.38)
SCHEMBL9629935 0.93 CYP2D6 (0.47)
SCHEMBL4662720 0.92 KMT2A (0.39)
SCHEMBL442261 0.86
SCHEMBL3740056 0.84 CYP2D6 (0.34)
SCHEMBL4661505 0.84 CYP2D6 (0.46)
SCHEMBL2859361 0.83 ALDH1A1 (0.41)
SCHEMBL6613931 0.82 CYP2D6 (0.44)
Hydrochloric Acid SCHEMBL3731244 0.81 ALDH1A1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0192522-B1 1-ETHYL- 3-HYDROXY-3-PHENYLPIPERIDINE, PROCESS FOR ITS PREPARATION AND ITS THERAPEUTICAL USE LABORATOIRE L. LAFON Société anonyme dite: (FR) 1988-08-31 EP claimed
US-20250206884-A1 ULTRAVIOLET RADIATION-CURABLE POLYSILOXANE COMPOSITION, AND DAMPING MATERIAL TAICA CORPORATION (JP) 2025-06-26 US disclosed
CN-119643673-A Method for monitoring tobacco fermentation process by online mass spectrometry 中国科学院大连化学物理研究所 2025-03-18 CN disclosed
CN-118974144-A Ultraviolet-curable polysiloxane composition and damping material 株式会社泰已科 2024-11-15 CN disclosed
EP-4447954-A1 HETEROCYCLIC COMPOUNDS AS 5HT2A BIASED AGONISTS Icahn School of Medicine at Mount Sinai (US) 2024-10-23 EP disclosed
WO-2023189433-A1 ULTRAVIOLET RADIATION-CURABLE POLYSILOXANE COMPOSITION, AND DAMPING MATERIAL 株式会社タイカ 2023-10-05 WO disclosed
US-20230192701-A1 BICYCLIC KINASE INHIBITORS AND USES THEREOF IOMX THERAPEUTICS AG (DE) 2023-06-22 US disclosed
WO-2023114472-A1 HETEROCYCLIC COMPOUNDS AS 5HT2A BIASED AGONISTS ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2023-06-22 WO disclosed
EP-3495341-B1 PREPARATION PROCESS OF PERFLUOROALKYL COMPOUND WITH MONOHYDROPERFLUOROALKANE AS STARTING MATERIAL KANTO DENKA KOGYO KK (JP) 2022-11-02 EP disclosed
CN-109563016-B Method for producing perfluoroalkyl compound using monohydroperfluoroalkane as starting material 关东电化工业株式会社 2022-05-13 CN disclosed
CN-1053613-A Nitrogen-containing spiro ring MERCK & CO INC (US) 1991-08-07 CN disclosed
EP-0432974-A1 Cyclic renin inhibitors MERCK & CO. INC. (US) 1991-06-19 EP disclosed
EP-0432975-A1 Cyclic renin inhibitors MERCK & CO. INC. (US) 1991-06-19 EP disclosed
EP-0431972-A2 Macrocyclic lactones having renin inhibiting properties MERCK & CO. INC. (US) 1991-06-12 EP disclosed
EP-0431943-A2 Nitrogen-containing spirocycles MERCK & CO. INC. (US) 1991-06-12 EP disclosed
EP-0192522-B1 1-ETHYL- 3-HYDROXY-3-PHENYLPIPERIDINE, PROCESS FOR ITS PREPARATION AND ITS THERAPEUTICAL USE LABORATOIRE L. LAFON Société anonyme dite: (FR) 1988-08-31 EP disclosed
US-4680302-A ANTIDEPRESSANTS LABORATOIRE L. LAFON (FR) 1987-07-14 US disclosed
EP-0192522-A1 1-ethyl- 3-hydroxy-3-phenylpiperidine, process for its preparation and its therapeutical use LABORATOIRE L. LAFON Société anonyme dite: (FR) 1986-08-27 EP disclosed
US-4209519-A 4-METHYL-6-METHOXY-8-AMINOQUINONE DERIVATIVES THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 1980-06-24 US disclosed
US-4005208-A GASTRIC JUICE, ANTISECRETORY SMITHKLINE CORPORATION (US) 1977-01-25 US disclosed